Cantharidin treatment for recalcitrant facial flat warts: A preliminary study

Journal of Dermatological Treatment

Volumn 20, Issue 2, 2009, Pages 114-119

  Kartal Durmazlar, Selda Pelinxs ^a,b   Atacan, Damla ^a   Eskioglu, Fatma ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Cantharidin; Flat warts; Topical therapy

Indexed keywords

CANTHARIDIN; FLUOROURACIL; IMIQUIMOD; RETINOIC ACID; SALICYLIC ACID;

ADOLESCENT; ADULT; ANNULAR WART; ARTICLE; BLISTER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; ERYTHEMA; EYE; FACE; FEMALE; HUMAN; HYPERPIGMENTATION; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REPEATED DRUG DOSE; SCAR; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE; VERRUCA VULGARIS; AGE; COHORT ANALYSIS; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; HOSPITALIZATION; INTRADERMAL DRUG ADMINISTRATION; PATHOLOGY; PATIENT SATISFACTION; RISK ASSESSMENT; SKIN DISEASE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGE FACTORS; CANTHARIDIN; CHILD; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FACIAL DERMATOSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT SATISFACTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WARTS; YOUNG ADULT;

EID: 67650327272     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630802287546     Document Type: Article

References (16)

1. Lio P. Warts, molluscum and things that go bump on the skin: a practical guide. Arch Dis Child Educ Pract Ed. 2007;92:119-24.
2. Hazard K, Karlsson A, Andersson K, Ekberg H, Dillner J, Forslund O. Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol. 2007;127:116-19.
3. Rivera A, Tyring SK. Therapy of cutaneous human Papillomavirus infections. Dermatol Ther. 2004;17:441-8.
4. Moed L, Shwayder TA, Chang MW. Cantharidin revisited. Arch Dermatol. 2001;137:1357-60.
5. Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol. 2000;43:503-7.
6. Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4:273-93.
7. Bacelieri R, Johnson SM. Cutaneous warts: An evidence-based approach to therapy. Am Fam Physician. 2005;72:647-52.
8. Sterling JC, Handfeld-jones S, Hudson PM. British Association Of Dermatologists Guidelines for the management of cutaneous warts. Br J Dermatol. 2001;144:4-11.
9. Kuykendall-Ivy TD, Johnson SM. Evidence-based review of management of nongenital cutaneous warts. Cutis. 2003;71:213-22.
10. Hengge UR, Esser S, Schultewolter T, Behrendt C, Meyer T, Stockfleth E, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol. 2000;143:1029-31.
11. Wu C, Langan S, Kilmuray M, Lawlor D, Watson R. Efficacy of pulsed-dye laser for viral warts - An internal audit. Ir Med J. 2003;96:8682-3.
12. Kopera D. Verrucae vulgares: Flashlamp-pumped pulsed dye laser treatment in 134 patients. Int J Dermatol. 2003;42:905-8.
13. Eldridge R, Casida JE. Cantharidin Effects on protein phosphatases and the phosphorylation state of phosphoproteins in mice. Toxicol Appl Pharmacol. 1995;130:95-100.
14. Ross GL, Orchard DC. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: A case series of 16 patients. Australas J Dermatol. 2004;45:100-2.
15. Polettini A, Crippa O, Ravagli A, Saragoni A. A fatal case of poisoning with cantharidin. Forensic Sci Int. 1992;56:37-43.
16. Langley JM, Soder JM, Schlievert PM, Murray S. Case report: Molluscum contagiosum. Toxic shock syndrome following cantharidin treatment. Am Fam Physician. 2003;49:887-9.